AAAAAA
Results: 1-25/39
Authors:
Spina, E
Avenoso, A
Facciola, G
Salemi, M
Scordo, MG
Ancione, M
Madia, AG
Perucca, E
Citation: E. Spina et al., Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia, PSYCHOPHAR, 153(2), 2001, pp. 238-243
Authors:
Perucca, E
Dulac, O
Shorvon, S
Tomson, T
Citation: E. Perucca et al., Harnessing the clinical potential of antiepileptic drug therapy - Dosage optimisation, CNS DRUGS, 15(8), 2001, pp. 609-621
Authors:
French, JA
Perucca, E
Richens, A
Citation: Ja. French et al., Special issue: Design of clinical trials of antiepileptic drugs - Preface, EPILEPSY R, 45(1-3), 2001, pp. 1-1
Authors:
Perucca, E
Citation: E. Perucca, Trial duration and follow-up, EPILEPSY R, 45(1-3), 2001, pp. 123-127
Authors:
Perucca, E
Citation: E. Perucca, Discussion: Trials in women, EPILEPSY R, 45(1-3), 2001, pp. 147-147
Authors:
Perucca, E
Richens, A
Citation: E. Perucca et A. Richens, Trials in the elderly, EPILEPSY R, 45(1-3), 2001, pp. 149-151
Authors:
Bialer, M
Johannessen, SI
Kupferberg, HJ
Levy, RH
Loiseau, P
Perucca, E
Citation: M. Bialer et al., Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V), EPILEPSY R, 43(1), 2001, pp. 11-58
Authors:
Spina, E
Scordo, MG
Avenoso, A
Perucca, E
Citation: E. Spina et al., Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity, J CL PSYCH, 21(1), 2001, pp. 108-109
Authors:
Battino, D
Croci, D
Granata, T
Mamoli, D
Messina, S
Perucca, E
Citation: D. Battino et al., Single-dose pharmacokinetics of lamotrigine in children: Influence of age and antiepileptic comedication, THER DRUG M, 23(3), 2001, pp. 217-222
Authors:
Perucca, E
Citation: E. Perucca, The management of refractory idiopathic epilepsies, EPILEPSIA, 42, 2001, pp. 31-35
Authors:
Genton, P
Guerrini, R
Perucca, E
Citation: P. Genton et al., Tiagabine in clinical practice, EPILEPSIA, 42, 2001, pp. 42-45
Authors:
Gatti, G
Furlanut, M
Perucca, E
Citation: G. Gatti et al., Interindividual variability in the metabolism of anti-epileptic drugs and its clinical implications, INTERINDIVIDUAL VARIABILITY IN HUMAN DRUG METABOLISM, 2001, pp. 157-180
Authors:
Furlanut, M
Wu, G
Perucca, E
Citation: M. Furlanut et al., Variability in the metabolism of levodopa and clinical implications, INTERINDIVIDUAL VARIABILITY IN HUMAN DRUG METABOLISM, 2001, pp. 181-227
Authors:
Spina, E
Avenoso, A
Facciola, G
Scordo, MG
Ancione, M
Madia, AG
Ventimiglia, A
Perucca, E
Citation: E. Spina et al., Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics, PSYCHOPHAR, 148(1), 2000, pp. 83-89
Authors:
Volosov, A
Bialer, M
Sun, XD
Perucca, E
Sintov, A
Yagen, B
Citation: A. Volosov et al., Simultaneous stereoselective high-performance liquid chromatographic determination of 10-hydroxycarbazepine and its metabolite carbamazepine-10,11-trans-dihydrodiol in human urine, J CHROMAT B, 738(2), 2000, pp. 419-425
Authors:
Gatti, G
Bonomi, I
Jannuzzi, G
Perucca, E
Citation: G. Gatti et al., The new antiepileptic drugs: Pharmacological and clinical aspects, CUR PHARM D, 6(8), 2000, pp. 839-860
Authors:
Schmidt, D
Gram, L
Brodie, M
Kramer, G
Perucca, E
Kalviainen, R
Elger, CE
Citation: D. Schmidt et al., Tiagabine in the treatment of epilepsy - a clinical review with a guide for the prescribing physician, EPILEPSY R, 41(3), 2000, pp. 245-251
Authors:
Perucca, E
Beghi, E
Dulac, O
Shorvon, S
Tomson, T
Citation: E. Perucca et al., Assessing risk to benefit ratio in antiepileptic drug therapy, EPILEPSY R, 41(2), 2000, pp. 107-139
Authors:
Parmeggiani, L
Belmonte, A
Ferrari, AR
Perucca, E
Guerrini, R
Citation: L. Parmeggiani et al., Add-on lamotrigine treatment in children and young adults with severe partial epilepsy: An open, prospective, long-term study, J CHILD NEU, 15(10), 2000, pp. 671-674
Authors:
Perucca, E
Citation: E. Perucca, Antiepileptic drugs, SIDE EFFECT, 23, 2000, pp. 83-95
Authors:
Perucca, E
Citation: E. Perucca, Is there a role for therapeutic drug monitoring of new anticonvulsants?, CLIN PHARMA, 38(3), 2000, pp. 191-204
Authors:
Spina, E
Avenoso, A
Facciola, G
Salemi, M
Scordo, MG
Giacobello, T
Madia, AG
Perucca, E
Citation: E. Spina et al., Plasma concentrations of risperidone and 9-hydroxyrisperidone: Effect of comedication with carbamazepine or valproate, THER DRUG M, 22(4), 2000, pp. 481-485
Authors:
Jannuzzi, G
Fattore, C
Gatti, G
Bartoli, A
Perucca, E
Cian, P
Monaco, F
Citation: G. Jannuzzi et al., Untitled - Reply, EPILEPSIA, 41(7), 2000, pp. 919-920
Authors:
Heaney, DC
Shorvon, SD
Sander, JWAS
Boon, P
Komarek, V
Marusic, P
Dravet, C
Perucca, E
Majkowski, J
Lima, JL
Arroyo, S
Tomson, T
Ried, S
van Donselaar, C
Eskazan, E
Peeters, P
Carita, P
Tjong-a-Hung, I
Myon, E
Taieb, C
Citation: Dc. Heaney et al., Cost minimization analysis of antiepileptic drugs in newly diagnosed epilepsy in 12 European countries, EPILEPSIA, 41, 2000, pp. S37-S44
Authors:
Jannuzzi, G
Cian, P
Fattore, C
Gatti, G
Bartoli, A
Monaco, F
Perucca, E
Citation: G. Jannuzzi et al., A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy, EPILEPSIA, 41(2), 2000, pp. 222-230